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ABSTRACT
Procaccini, Rob e rt Louis. Ph.D., University of Rhode Island,
June , 1972. Glyoxal and Estradiol Mediated Alterations in Rat
Uterine Histone Acetylation. Major Professor: Dr. David R. DeFanti.
The immature rat uterus was developed as a model in which to
measure alterations in his tone acetylation in a target organ following
hormonal stimulation.

The effect of various glyoxal derivatives on

his tone acetylation and several other parameters was measured in the
uterine tissue of untreated and estradiol treated animals.

Six day

treatment with glyoxal monohydrate and methylglyoxal-bis-guanyl hydrazone (Me thyl-GAG) decreased uterine wet weight and p ar tially
blocked e stradiol m.edi ated alterations in uterine vvet we ight in animals
r eceiving concomitant e stradiol and glyoxal tr eatment.
The dose dependent in vitro inhibition of uterine histone acetylation
is thought to oc cur through direct action on the ac e tyl ation system..

1

50

Th e

values reported for methylglyoxal and phenylglyoxal suggest that the

dru gs are equally effective as inhibitors of uterine histone acetylation .
Estradiol mediated alterations in uterine histone acetylation
were char acterized as a r apid depression of enzyme activity; 24 hours
follo wing horn1onc treatme nt thi s enz ym e activity was el8vatcd above
control l eve l s .

The elevation in his tone ace tyl ation following estradiol

tr eatment wa .s bloc ked by eiLli.er methyJglyox a l or
administc1·ed 20

hour~

afi:cr

est~aciol.

ph'"~ny lglyoxal

Ut.erine \\·c l· \veight, total DNA,

RNA/DNA and protein/DNA ratios were not affe cted by this treatment.
These data suggest that histone acetylation may not be of primary
importance in estradiol stimulation of the rat uterus.
The phenylglyoxal mediated depressio-n of uterine histone acetylation preceded the alterations in RNA/DNA and prote in/DNA ratios
obs erved when phenylglyoxal pretreatment was extended to 48 hours.
Elevations in total DNA and protein/DNA ratios in the uterus of
estradiol treated rats were partially suppressed in animals pretreated
with phenylglyoxal, whereas the RNA/DNA ratio was not affected in
these animals.
Results from this study suggest th a t the glyoxal mediated
blo ck ad e of uterine histo ne acetylation ina. y lead to an alteration in
nucleic acid content of the hormonally stimulated uterus.
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I.

INTRODUCTION

The biological activity of glyoxal derivatives (ketoaldehydes)
has been the subject of numerous literature reports.

In 1967,

Sz ent-Gyorgyi proposed that these compounds may inhibit cell growth .
Interestingly, methylglyoxal and propylglyoxal were sho w n to inhibit
cell division in mouse lymphoma cells (Gregg, 1968).

Klamerth (1968)

suggested that glyoxal may elicit its cellular inhibitory properties at
the DNA r e plication level.

Scaife (1969) has pr esented evidence that

\'- ethoxy- o(-ketobutyraldehyde (Ketho xal, Upjohn Phar maceutical)
inhibits cell division and protein synthesis .

Although kethoxal and

ano the r ketoaldehyde, methylglyoxal-bis -guanylh yd ra zone , h ave b een
used therapeutic a lly for l eukemia , the exac t antileukem.ic mechanism
is not known (H enderson , 1969 ).
Con comi t antl y, a growing body of obs ervations (A llfr ey e t al.,

1963 ; P ogo ct al., 1966, 19 68 ) indicates that histone m e tabolism., in
particul ar , his tone acetylation, may b e involved in r egulating DNA
fun c tion.

The i nhibitory action of histone s on cellular processes may

it self b e regulated, in part, by th e acetylation reaction (Gcorgiev ,

1969; Tsanov and Scndov, 1971).

It follows th at inhibition of histone

ac etylation n1ay l ead to alte rations in ov e rall histone function.

In

addilion , pr evious workers hav e report ed (Po go et al. , 1966 ) alt e rations in hi s tone acetylation follo"ving ho rmonal stimulation.

2
As a result, this investigation was designed to study the effects
of glyoxal derivatives on histone acetylation in a hormonally alterable
system.

ll.

LlTERATURESURVEY

During the past two decades, numerous investigators have tried

to elucidate the structure, mechanism of action, and general cellular
function of his tones.

Becaus e

these low molecular weight, highly

alkaline proteins are closely associated with deoxyribonucleic acid in
the nuclear apparatus of cells, early investigators focused their
attention on the search for proof of a regulatory function involving the
histones.
Th'e first hypothesis was pr esented by Stedman ancl St edman

(1950) that histones were inhibitors of genetic activity.

Later, the

suggestion was made that the evolution of the structure and funclion of
various histo ne species parallels, to some degree, the evolution of
the genes themselves.

G eorgiev (1969) stated that histones appeared

in evolution at the san1e time the cell acquired t wo of its fundamental
proper ti es:

a nuclear n1embrane and the capacity for diffe rentiation.

D eLange and Smith ( 1971) pointed out thal evolution ary conservatism
is evident in the structure of his tone s.

Histone IV (argini ne -rich),

with an approximate evolutionary mutation rate of 0. 06 /100 residues/

100 niillion years, is 33
prote in.

tin~ es

more genetically stable than any known

It h as been proposed that the biological function of the

his ton e s dernancls su c h close control of it s structure that even slight
modifications in its amino acid sequence could not be tolerated
(Bradb ury , 1969).

4
STRUCTURE AND FUNCTION OF HISTONES
Approximately 15 percent of the nuclea r component of eukaryotic
cells is composed of his tone protein.
exist in five distinct fractions:

The hi stones are beli eve d to

fl, lysine-ri-ch; f2b, moderately

lysine-rich; and f2al, f2a2, and £3, arginine -ri ch histones.

Each of

the fractions is thought to comprise 20 percent of the whole histone
(Richards and Pardon, 1970).

Virtually all of the deoxyribonucleic

acid (DNA) in the nucleus exists as a complex with histones.

It is

generally beli e ved that his tones attach to DNA through electrostatic
linkages.

Of these, the strongest are ionic linkag es betwee n the

phosphate groups of the DNA and the basic r e sidues lysine
arginine (guanidinium), and histidine
Lewin, 1970).

(f ammonium) ,

(Richards and Pardon , 1970;

Comb ard and V enduly (1970) presented evidence

indicating that different histone fractions intera ct wi th DNA at different
sites on the DNA molecule.

They found lysi ne -rich histones in

associ ati on with DNA in regions of r e latively high adenine-thymine bas e
content , where as a!ginine -rich hi stones we re foun d in association wi th
guanine and cytosine -rich regions.
Not all th e his tone fractions affect the activity of th e DNA
complex to the same extent; for ex:am.ple , ly sine -ri ch his tone (£1)
inhibits the DNA-depen dent-RNA polyrneras e r eaction to a l esser
extent than does the arginine-rich histone (£3).

Further, prior acetyl-

ation of uterine histone m .arkedly depresses the inhibitory effect of

5
his tones on in vitro RNA synthesis (Teng and Hamilton, 1969).

The

inhibitory effect of arginine-rich histone fractions on DNA dependentRNA polymerase is thought to be related to the thiol/disulfide ratio of
the fraction.

Hilton and Stockton (1966) found that diffuse, active

chromatin has a greate r proportion of sulfur residues as free thiol
groups than does dense, inactive chromatin.

Purified f3 histone was

annealed with DNA, and purified RNA polymerase was used to measure
the efficiency of the treated DNA as a template .

When hi stone thiol

groups were oxidized to the disulfide form before th e annealing step,
his tone -hi stone aggregates we re produced which possessed augmented
inhibitory prope rties against DNA template activity.

These result s

sugg es ted that continuous RNA synthesis in mammalian cells may be
partly dependent upon the existence of cyste ine -containing histones in
the ir thiol form (O!'d and Stacken , 1969).
Extens ive stuclies of his tone metabolism in mammalian cells
indicat e th at th ese prote ins undergo structural alterations by at l eas t
three enzymatic processes:
Pogo~

(1)

acetylation (Allfr e y ~_!_al., 1964;

al. , 196 6 ; Pogo et al., 1968),

19 6 9; Paik and Kim., 1971), and

(2) mcthylation (Paik and Kim,

(3) phosphorylation (L angan, 1969).

The enzymatic modification of his tone protein may r epresent an
early event in the co1nplex process of gene activation for subsequent
RNA and protein synthesis (Po go~ al., 19 68 ).

To support thi s th eory ,

s evera l n1odel systen1s have b een proposed for the study of hislones

6
and their enzymatic modification during periods of increased growth
b elieved to involve enhanced genetic activity.
Incorporation studies have established that transformation
(activation) of human lymphocytes by phytohemagglutinin involves an
increase in RNA synthesis (Rubin and Cooper, 19 63) and in protein
synthesis (Bach and Hirschorn, 1963), using uridine-2alanine -l-

14

c,

respectively.

14

c

and

Incr eased histone acetylation seen in

response to phytohemagglutinin preceded the increase in RNA and
protein synthesis; at the same time, cells not stimulated by phyto hemagglutinin did not demonstrate this increase in acetylation of their
his tones (Pogo et al. , 1966 ).
Pogo~

turnover of

3

al. (19 68) , studying rat live r r egenerati on, showed that

H-acetyl groups incorporated into histones decreased in

partially hepatectomized rats.

Rates of 3 H-UMP in corporati on i nto

itNA r each ed maximum leve ls only after histone acetylation had peaked.
Pogo ( 196 9) found that nucleolar activation in this system began at 2
hours and chromatin activation at about 6 to 8 hou1·s after partial
hep a tectomy.

He also found tha t ar ginine- rich (f2 al ) histones were

highly and r apidly acetylated.

When the acetylated histones were

treated with 2M hydroxylamine for one hour, all th e l abeled a cet ate was
found to be r esistant to cleavage fro1n his tone.

Si nce hydroxyl amine ,

und er t hese conditions , will hydrolyze 0-ac ety l but not N-acetyl
linkages, and since, under si1nilar condi t ions , the histone fraction f3

7
(arginine-rich) lost 55 percent of its acetyl content, the presence of
0-acetylated groups was indicated.

Verifications of the presence of

radioactive acetyl groups was accomplished by acid hydrolysis and
steam distillation of volatile acetic acid.
An extensive study by Paik and Kim (1971) has shown that at
least three enzymes found in the cytosol fraction of calf thymus are
capable of methylating histones.
me thionine:

Protein methylase I(S-adenosyl-L-

protein-arginine me thyltransferase) methylate s the

guanido group of arginine residue s in histones yielding a product
identified as W -N -methylarginine.

When protein methylase I was

m easu red in rapidly growing h epatoma , the enzyme activity was fo und
to increa se by 50 to 100 percent

(Paik~

al., in press).

Kaye and

She ratyky ( 19 69 ) obtained an enzyme pr eparation from the 105, 000 x g
supe rnat ant fraction of rat or gans which they found c apable of trans fer ring methyl grou ps fro1n S- adcnasyl-L -me thionine and acetyl groups
fro1n acetyl-COA to arginyl and lysyl residues in histone s.

The most

effective acceptors were unfractionated histones of rat organs, calf
thymus arginine -rich hi stones and poly-L-arginine .
An enzyme systen1 deriv e d from r at brain nucle i selectively
catalyz ed the acetylation of histoncs , using acetyl-COA as acetate
dono r

(Bon dy~

a l., 1970 ).

ati ng arginine-rich histones .

The preparation \Vas most active in acetylHistone acetyla se prepar e d fro1n nucl e i

of adult rat brains exhibited greater activity than did similar

8
preparations obtained

fron~

th e brains of newborn rats.

In contrast,

brain cytoplasmic enzyme was low in both specificity and activity.
Treatment of cerebral chromatin with a solubiliz ed acetylase preparation augmented the template activity of the treated chromatin for RNA
synthesis .
Non-enz.ymatic acetylation of histones has b een reported by Paik
~al.

(1970); howe v e r, the reaction occurs almost exclusively in

nuclei and has a pH maximum of 10. 0.
!moue and Fujimoto ( 1969) report a hi stone deacetylating en z yme
pre sent in calf thymus extracts .

The significanc e of this enzyme in

biolo gical systems , howe ver, is not known.
It is evident from these studies that histone modification is an

active process occur ri ng most significantly during periods of enhanced
cell growth .

Measurement in several sys terns indic ates that histone

modific a tion, particu l ar ly acetylation, prec edes or accompanies
incr eases in DNA-dependent-RNA polymerase activity and RNA
synth esis in stimulated cells (Wilhe l m and McCarthy , 1 970) .

Ho we ver,

neither direct proof for the involvernent of histones nor their modification in th e control of RNA synthesis is yet available (G eorgiev , 1 969;
D e Lange and Smith, 1 97 1).

HISTONES AND NUCLEAR MECHANISMS
Butler (19 66 ) proposed a mechanism for the r egul ation o f gene
activity involving an interaction between hormone , t arget protein, and

9
histone.

According to his model, the hormone, upon reaching its target

organ, would be spe cifically and p refe rentially bound to a targ e t cell
prote in with subs e quent formation of a protein-hormone complex.
This complex would then attach or some ho w inte r a ct with DNA-associated his ton e and either remove the his tone from the nucleo prote in
complex or diminish the degree of binding betwee.n DNA and his tone.
The no w d e repress ed DNA segme nt w ould be fre e to take part in nuclea r
transcriptional functions.

This model b e comes most plausible w hen

vie we d in light of recent findings that various steroid hormone s are
c apable of increasing DNA templat e activity, RNA synthesis , and
protein sy nthesis in their resp ecti ve targ e t or gans (H amilton , 19 68;
Kenney et al. , 1968; Avd a lovic and Kochakian, 19 6 9).

The biolo gical

activity of at l ea st o ne st er oid hor mone , es tradiol - 17-~, is b elieved
to b e initiated by t he attachment of hor mone to a cytoplasmic "r ece ptor"
protein , followed by translocation of the hormone -protein complex
into the cell nucleus (J ensen~ al. , 196 8 ; M uell e r, 1971; Truong and
Bauli eu , 1971).

~h e

early actions of this hormone on i ntac t i mma ture

and ovari ect omized rat uterus i s we ll document ed {Teng and Hamilton,
19 69; Bresnich , 1 971 ; and ·Mueller , 1 97 1).

It is generally accepted

th at the action of estradiol on its t arge t organ i nvolves , i n part, an
activati on of nuclear mechanisms for genetic expre s sio.n (Mue lle r ,
1971).

E str adiol may dir ectly affec t the t emplat e activity of uterine

d e o xyr ibonucleopr otein , which is firn1ly attached to RNA po lyn1erase .
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This action is thought to explain the obs e rved increas e in RNA synthesis
without an appar ent increase in RNA polymeras e following estradiol
a dministration (Gorski

~al.,

1965).

-

From 0-24 hours follo w ing estradiol treatment, synthesis of
uterine histones remain unchanged.

However, at 12-24 hours follo w ing

hormone treatment, the rate of chromatin-directed RNA synthesis in
vitro decreases, whereas RNA l evels increase during the latter stages
of estrogen action .

From thes e ob servations , Gorski ~al. (1965)

suggest that estradiol may alter the metabolism of ute rine RNA.
Teng and Hamilton (19 69), investigating the involvement of
his tones in es tro geni c action recently demonstrated that uterine hi stones,
particularly arginine -rich fractions, ar e capable of inhibiti ng uterine
chromati n-directe d RNA synthesis , in vitro.

In vivo stimulation of

t emplate activity by estradiol-protected RNA synthesis in vitr.2 from
the inhibitory effects of added his tone.

Estradiol , added in vitro at

fin a l concentrations of 10- 5 - l0- 6 M, did not protect uterine
chromatin-dir ecte d RNA synthesis from inhibiti on by the histones .
The amount of arginine - rich hi stones in association w ith uterine
chromatin decreases duririg th e first hour of estradiol aclminist ralion
(Barker, 1971).

It is not knovv n whether the his tones are n~etabolizecl

throu gh protolysis or are complexed with non-histone protein.

The

pr esence of a specific enz y me capable of degrading histones (histo ne
hydrol ase ) has b ee n r eported in an amphibian system (Paik , 1971 ).
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Libby (1968) reported the presence of a soluble enzyme present
in inunature rat uterus, which is capable of acetylating his tone.

In

this study, addition of estradiol in vitro stimulated histone acetylation.
The ability of estradiol to stimulate histone acetylation in vivo during
the first 15 minutes of hormone treatment has been demonstrated by
Libby (1971) .

Howeve r, Anderson and Gorski (1971) reported that,

after introduction of estradiol, histone acetylation was at first depress e d
but then rose, beginning at about 12 hours and elevating above control
levels at 24 hours following hormon e treatment.

In their studies with

protein methyla se, Kaye and She ratzky (1969) found that estradiol-1 7 ~.

preincub a t ed with a 150, 000 x g supernatant fraction of imma tur e

rat ute rus a nd then added to a standard as say, dee reased th e methylation of histo ne by 10 p e rcent.

Furthe rmor e , estradiol-17-

0,

administered 50 pg/r a t, subcutane ou s ly, for 3 d ays decreas ed histone
methylation by 50 p ercent, measured in vitro.
Steroid hormones are c apab l e of dir ec t attachment to histones
both in vitro and in vivo (Sluy ser , 1966; Sunago and Koide, 1967;
Sluys e r, 1970).

The greatest extent of hor monal i nte raclion w ith

histon es o ccurs with arginine-rich histone fractions.

The effects of

such interactions could be considerable, since histone attachment to
DNA rn.ay involve ly syl and arginyl histone residu es (Le\vin , 1970).
The in teracti on behveen cortisol -1, 2-t and histones is thought to
b e dependent on th e presence of 21-d chydrocorlisol , a co ntaminant in
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most corticosteroid preparations and the possible active metabolite of
cortisol in vivo (DeLange and Smith, 1971).

In studies p e rformed by

Mande r and Walker (1970), cortisol and 21-dehydrocortisol, a steroid
with a glyoxal moiety in its structure, reacte d with all histone fractions
tested in vitro.

However, both steroids were bound most extensively

to arginine-rich histones.

Blockade of arginyl histone residues by

gloxylation (Freedman~ al., 1968) greatly diminished binding of
21-dehydrocortisol and eliminated binding of cortisol to the histones.
In addition, the results indicate tha t corticosteroid binding to histones
may r e quir e prior oxidation of the ste roid.

The actual binding site

may involve covalent inte ractions b e t ween th e steroids and residues of
the basic amino acids, arginine and lysine, in hi stone protein.
Howe v e r, th e biolo gical significance of th ese intera ctio ns has not been
assess ed .

GLYOXALS AND THEIR CELLULAR MECHANISMS
Glyoxa ls ar e ke toald eh yd es clos e ly related to trio ses and other
basic metabolites .

They reportedly exist endogenous ly in hi gh con-

cent rations (S zent -Gyor gyi , 19 6 7).

Examples of endogenous metabolism

leading to the formation of glyoxals includ e glycine to m e thylglyoxal
and ascorbic acid o xida tion to d eh ydroascorbat" (Edgar , 19 69 ).

The

latter compound contains a glyoxal inoiety in its structure and
report edly possesses antitumor prope rties (Edgar , 19 69).

Methyl-

glyoxal is rn.e taboliz e d to lactic acid by h v o closdy related enzymes ,
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glyoxylase I and glyoxylase II (French and Freelander, 1958).

Vince

and Wass (1969) are exploring the possibility of inhibiting the glyoxylase system in order to potentiate the carcinostatic activity of
methylglyoxal.
Sz ent -Gyor gyi (1968) has proposed that endogenous inhibitors of
cell division may include molecular spe cies containing a glyoxal

0
II

group (R -

0

II

C - C - H).

In advance of this proposal, Szent-Gyorgyi

stated that cells possess an unlimited source of meta bolically
available electrons but are deficient in electron acceptors.

Sulfhydryl

groups involved in the complex mechanisms of cell proliferation and
prote in sy n thes is wou ld exist in their thiol form and could b e oxidized
to the disulfide form by glyoxals and th ere by b e inactivat ed .

In

subsequent studies, th e glyoxals, particularly methylglyoxal and
propylglyoxal, inhibited cell division in both bacterial and mammali an
cells

3
( ascites tumor} at concentrations of l0- M (Egyud and S zent -

Gyorgyi, 1966).

Incorporation studies demonstrated that, although

prote in synthesis was blocked to

a

greater extent , both DNA and RNA

synthesis was inhibited by the glyoxals (Egyud and S zent -Gyor gyi , 1966).
Methyl g lyo xal and propylglyoxal i nhibi t cell division i n mouse
lymphoma (L-5 l 78Y) by t heir ability to block protein synthesis (Greg g ,
1968), whereas glyoxal inhibits DNA synthesis as \.vell as protein
synthesis in human fibroblasts (Klamerth , 19 68) .

Sc aife (19 69 )

measured 3H-uridinc incorporation into RNA and 3 H-thyrnidine
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incorporation into DNA in human kidney cells grown in monolayer
culture and treated with methylglyoxal or Kethoxal ( 0-ethoxy-o<ket·-0-butyraldehyde).

Although DNA, RNA, and protein synthesis

were inhibited, the most pronounced effe c t of these compounds was the
blockade of DNA and protein synt hesis.
Procaccini

~al.

(1971) used a soluble rat uterine enzyme to

study the inhibition by methylglyoxal and phenylglyoxal of histone
acetylation in an i n vitro system.

They postulated that, if such an

inhibitory effect is accomplished in vivo, it might offer an alternate./
additional explanation to the known inhibitory properties of the glyoxals
on cell division and proliferation.
Interestingly, two glyoxal derivatives, methylglyoxal-bisguanylhydrazone (Methyl-GAG) and Kethoxal have found limited use in
the treatment of leukemia (Freireich ~al., 1962; French and
F reelander, 1958).

However, the exact mechanism of action of these

drugs is not yet known (Henderson, 1969).

III .
A.

EXPERIMENT AL

ANIMALS
Immature (22-30 day old) female rats (Sprague -Dawley strain;

C harles River Breeding Laboratories , Wilmington, Massachusetts)
were housed in quarters maintained at 70°C supplied with 12-hour
a lternating c y-cle of light and dark.

Animals we re offered food

(Purina Rat Chow, Ralston Purina Company , S t. Louis, Missouri )
and water , ad libitum .

However, food was removed 24 h o urs prior

to sacrifice in the case of 24 - hour time-course studies .

B.

SUBCELLULAR FRACTIONATION AND LOCALIZATION OF
HISTONE ACETYLATING ACTIVITY: SPECIFIC ACTIVITY
Eight immatur e (25 day old) female rats were sacrificed by

cervical dislocation.

The uterin e tissue wa s cleaned of connec tive

tissue , in situ, excised , blotted and weighed .
"ve re

hon~ogenized

The pooled tis sues

in 9 volumes of 0. 25M cold sucrose solution using

a Tri-R homogenizer (Tri-R-Instrurn.ents , Rockville C ent r e , N ew York).
The homa ge nate d were pooled, sepa rat ed into 15 ml Nalgene centrifuge
tub es and centrifuged at 780 x g (2, 500 RPM) for 10 minutes at

o0 c

in

a S ervall r efrige rat ed centrifuge (Sorv all , Inc., Norwalk, Connec ticut).
The supernat ant was tr ansfer r ed to another s et of tub es and c entr ifuged at 10, 000 x g (9, 500 RPM) for 15 minutes.

The nnclear fraction

was resusp ende d to volun1e in 0. 25M su crose solution and centrifuged
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as before.

The resultant supernatant was decanted and discarded, the

nuclear pellet was resuspended to' volume with Robinson's media
(Robinson, 1949), placed in glass screw-cap vials and frozen at -40°C
until required for assay.

The 10, 000 x g supernatant fraction was

transferr ed to straight-walled plastic centrifuge tubes, capped and
centrifuged at 105, 000 x g (32, 000 RPM) for 1 hour at

o0 c

in an IEC

Pre pa ration Ultracentrifuge (Mo del B -60, International Equipment
Company , Needham Heights, Massachusetts) equipped with an A-170
aluminum h ead .

The mitochondrial fraction was resuspe nded to

volume in 0. 25 M sucrose solution and centrifug e d at 10, 000 x g as
before.

The resultant supe rnatant was discarded.

The mitochondrial

fraction was re suspended to volume in Robinson's media, transfc r red
to screw-cap vials and stor ed at -40°C until requir ed for assay .

The

105, 000 x g supernatant fraction was tr ansferred to storage vial s and
froz en as above .

Th e microsomes were was h ed twice with 0. 25M

sucrose solution, resuspended to volume in Robinson's media, and
stor ed at -40°C until needed for assay.

An aliquot of the thawed

fraction requir ed for assay of histone acetylation activity was used for
protein detern1inations on ·all subcellular fractions.

C.

IN VITRO S TUDIES

1.
(Q10).

Tern.perature study : Deternrination of t e 1nperature coefficient
Co mponents of the con.1.plete assay syste1n previously described

were incub ated in a Dubnoff metabolic incub ator shaker (Dubnoff ,
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.

0

Precision Sci entific Company, Chicago, Illinoi s ) s e t at 30 , 37°, 40°,
45°, 50°, 55°, and 60 °C for 30 minutes.

Histone acetylating activity

at the various t emperatures was determined.

These data were

inserted into the van't Hoff equation to det e rmine the Q10 value:

log QlO

=

10
tz - t1

log

kz
k1

kz - r eacti on rate at temperature tz

where:
and

2.
of 150.

k1

= reaction

rate at t emperature t 1

Dose response for methyl- and phenylglyoxal : d e t e rmination
Phenyl glyoxa l (Pfal z and B aue r) and me thyl glyo xal (Aldrich

Chemical) were dissolv ed in 0. 5 M phosphate buffe r, pH 7. 7 prior to
use.

Various conce ntra tions of drug s we r e pr e incub ated in the

pres ence of enzyme in the assay m edj um at 37°C for 15 minutes;
his to ne was add ed , and the r eac tion was allo we d to p roceed for an
additio na l 30 minutes .

The d ata we re plotted (% inhibitio n vs . dru g

concentration ), and the 150 v a lue (d rug concentration at which 50 p e rcent
inhibition is ob served ) was d e l e r mined graphically .
3.

Effec t of enzyme -d rug_ and hi stone -drug pr eincubatio r,

ace tyl ation .

o_:r:_~~~tone

(a ) En zyrn.e - D rug : Phe nylglyo xal was dis sol ved in 0. 0 5 M

phosphate buffer pH 7. 7, to a co ncentration of 10- 2 M .

Fron1 this stock

solutio n , serial dilutions of 1 o- 3 M and 10 - 4 M phenyl glyoxal we re
pr e p ared .

A

0. 25 n1l aliquot of each conc en t ra tio n of phenylglyoxal

was tr ansfer r ed t o each of three tub es cont a ining 0. 25 ml of l 0, 000 x g
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uterine supernatant fraction in concentrations of 5 x l0and 5 x 10- 5 M phenylglyoxal, respectively.
were mixed and incubated at 3 7°C.

3

M, 5 x 10- 4 M,

The contents of the tubes

At the end of a 10 minute pre -

incubation period, a 0. 1 ml aliquot of each mixture was transferred to
tub es containing all components of the standard assay system with
exception of uterine supernatant.

The tube contents were mixed and

incubated , with shaking, for 2 0 minutes at 3 ?°C.

Uterine supernatant,

preincubated with phosphate buffer constituted the control samples.
Standard procedures for the detennination of hi stone acetylation activity
were performed on each sample.
(b) Histone -Drug: Solutions of phen ylglyo xa l at concentrations of
10-2 M, lo- 3 M and lo-4 M were prepared as before.

A 0. 6 ml aliquot

of a freshly prepared solution of calf thymus histone (10 mg/ml) was
added to tub e s containing 0. 6 ml of phenylglyoxal solution at various
concentrations spe cified.

The resultant mixtures, containing phenyl-

glyo xal at concentrations of 5 x lo- 3 M, 5 x 10- 1 M and 5 x lo-5 M,
respectively, were incubated, with shaking, for 10 minutes at 37°C.
Following this period, a 0. 2 ml aliquot containing 1. 0 mg of hi stone
requir ed for assay was tr a.nsfc r red to tubes containing all components
of the assay system. wi th th e exception of his tone .

The completed

mixtur e was then incubated for an additional 20 rn.inutes at 37°C with
shaking.

H is tone, preincubated with buffer , cons titutecl the controls.

Assay of h is tone acetylating activity of the various samples '.vas
accomplishe d as above.
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D.

IN VIVO STUDIES

1.

Tissue Weight: Alterations with Estradiol and Glyoxals.

Immature female rats (26 days old}, weighing 70-90 grams, were
divided into groups of five animals each.

Groups were housed in

plastic box cages furnished with wood chip bedding.
allowed food and water ad libitum.

Animals were

Solutions of drugs in 0. OSM phos -

phate buffer (pH 7. 4) we re prepared fresh daily and administered
according to the following schedule:
(1) phosphate buffer, 1 ml/kg, intraperitoneally, for 6 days,
plus 0. 2 ml saline subcutaneously, every 12 hours for 60
hours, starting on day 3 of schedule.
(2) phosphate buffer, 1 ml/kg, intraperitoneally, for 6 days,
plus estradiol-17- ~ dipropionate (Mann Resec:uch Labs} 0. 2 ml
(12 ug) subcutaneously, every 12 hours for 60 hours, starting
on day 3 of schedule.
(3)

glyoxal monohydrate, 200 mg/kg, intraperitoneally, daily

for 6 days.
(4)

glyoxal monohydrate, 200 mg/kg, intraperitoneally, daily

for 6 days, plus estradiol, 0. 2 ml, subcutaneously, every 12
hours for 60 hours, starting on day 3 of schedule.
(5) methylglyoxal-guanylhydrazone (methyl-GAG, Aldrich
Chemical) 20 mg/kg, intraperitoneally, daily for 6 days.
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(6)

methylglyoxal-guanylhydrazone, 20 mg/kg, intraperitoneally,

daily for 6 days, plus estradiol, 0. 2 ml, subcutaneously, every
12 hours for 60 hours, starting on day 3 of schedule.
Rats were sacrificed by cervical dislocation.

The liver of each

animal was perfused in situ with cold 0. 25 M sucrose solution, removed,
weighed, and placed on ice.

The uterus was surgically cleane d of

connective tissue, excised, press blotted and weighed.

The liver and

uterus from e ach animal was homogeniz ed separately in 9 volumes of
Robins on 1 s medium (Robinson, 1949), using a Polytron homogenize r
(Spe e d #6 for 15 s e c.), follo we d by centrifugation at 10, 000 x g
(9, 500 RPM) for 10 minutes at
(So rva l, Model RC2 - B ).

o0 c

in a S e rv a ll Refrigerated C entrifuge

The sup e rnatant fraction of li ver and uterus

was transferred in 1. 0 ml aliquots to 5 ml glass screw-cap vials and
sto red at -40°C u nti l r equired for enzymatic assay.
2.

Es tradiol and Phenyl glyoxal: I ni tial respo nse .

solution of es tradio l-1 7 -

f.>

A stock

(S cwartz-Mann ) was p repared by dis solving

25 mg of the hormo ne in 100 ml of 95% ethyl alcohol.

At the time of

administration , 1. 0 m l of e thanolic stock solution was slowly added to
3. 0 ml of salin e w ith con. s t.a n t slirring t o prepare a su spens ion contai ning 60 p g /ml of estradiol.

At th e time of inj ec tio n (treatment 2)

each rat r eceive d approximate ly 12 p g of es tr acliol (0. 2 ml ) s ubc ut aneous ly.

A freshly pr epa r e d sol ution of phenylglyoxal rnonohydrate

in 0. OSM phosphale buffer was ad j usted to pH 7. 4 v:ith 0. SN NaOH .
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Four groups of eight, 26-day old female rats were administered phenylglyoxal, 250 mg/kg, intraperitoneally (Treatment 1).

At the end of

one hour, each animal received e stradiol, 12 pg I rat, subcutaneously
(Treatment 2).

Groups receiving estradiol, following phenylglyoxal

pretreatment or estradiol alone, were sacrificed at 0, 5, 10, and 15
minutes following estradiol treatment.

Control animals receiving

1 ml/kg of 0. 05M phosphate buffer alone were sacrificed one hour
following injection.

Rats were sacrificed by cervical dislocation.

Individual uterine tissue was press blotted, and weighed , and the
pooled tis sues from two identically treated animals were homogenized
in 9 volumes of cold Robinson's media.

The 10, 000 x g supernatant

fractions were stored at -40°C in 5 ml glass screw-cap vials until
required for assay.

Protein determinations of the supernatant fractions

obtained from experimental groups were carried out by the method of
Lowry

~al.

(1951 ).

Students "t" test was employed to dete rm.ine

statistical differences between treated and untreated groups.
3.

Activity of Estradiol and Glyoxals: Time response.

Immature (25 day old) female rats were divided into groups of 6 to 8
animals.

Control groups received 1 ml/kg of the drug vehicle, 0. 05 M

phosphate buffer (pH 7. 4) or estradiol vehicle .

Rats were administered

either estradiol-17- ~. 10 ug/rat, intraperitoneally, or phenylglyoxal,
250 mg/kg, intraperitoneally.

Animals treated with either drug were

sacrificed at 1, 2, 4, 8, 16, and 24 hours follo\.ving drug adm.inistration.
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Rats were sacrificed by cervical dislocation.
surgically cleaned , blotted and weighed.

The uterine tissue was

For histone acetylation

studies, tissue s from two rats we re pooled and homogenized in 9
volumes of Robinso n' s m edi a.
uteri~e

Furthe r preparation and storage of the

extract for subsequent analysis of his tone acetylation activity

was as described previously.
4.

Drug Interaction: Estradiol and Glyoxals.

Thirty day old

female rats were divided into groups of 8 to 10 animals.
administered estradiol , 10 ug/rat, intraperitoneally.
received estradiol vehicle as described previously.

Rats we re

Control animals
At 2-0 hours

following hormone treatment, estradiol freated rats received either
methylglyoxal (125 mg/kg or 250 mg/kg) or phenylglyoxal (250 mg/kg),
intrape ritoneally.
of the glyoxals.

Vehicle treated rats also received the same doses

Control rats recei ved 1 ml/kg of the drug vehicle,

0. 05 M phosphate buffer (pH 7. 4).

Groups of animals were

inj~cted

at appropriate intervals in order to account for .the time_ required for .
sacrifice of each group.

All animals were sacrificed 2.-4 hours after

estradiol administration (4 hours follo wing glyoxal a:dministration).
Protocol follo wed after sacrifice, involving weig_hing, uterine
extract preparation and assay were as described previously except
that tissues from this study were not pooled .
were carried out by the m ethod of

Lowry~

Protein determinations -

al. (1951).
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E.

ASSAY OF HISTONE ACETYLATION
The procedure for the analysis of histone ac etylation is a mod-

ification of the method of Libby (1968).

A 0. OS ml aliquot of a 10, 000

x g supernatant fraction of rat uterus (prepared as previously d es cribed)
capable of acetylating histones was routinely employed as the enzyme
source in the assay system.

The assay mixture contained, in addition

to the supernatant fraction, 100 umoles of phosphate buffer (pH 7. 7),
S umoles ATP (Sigma Chemical Company) solution adjusted to neutrality with 0. SN NaOH, 0. OS umolcs co enzyme A (Cal-Biochem ), Su C
Na-acetate -l-

14

c

(New England Nuclear; specific activities of S7-60

millicurie s /millimol e ); and 1. 0 mg calf thymus his tone (Worthington
Biochemicals and enough distilled water to make a final volume of 1. 0
ml.

Components of the incubation mixture were pipet ted into lS ml

Nalgene tubes.

All drug pr eparations were made in the buffer used for

enzyme incubations.
0

Incub ations were carri ed out in a Dubnoff metabolic

sh aker at 37 C under air .

Following the pr es cribed incub a tion tin1.e, the

reaclio n \vas terminated by the addition of S m l of cold acetone.

The

tub es were seale d with Parafiln1. (American Can Company, N ee nan,
Wis cons in), mixed by inversion and allowed to stand in a freezer at
-40°C for approx imate ly 30 minutes.

The tubes we re then centrifuged

for 10 minules at 10, 000 x gin a Sorval Model RC2-B refrigerated
centrifuge at 0°C.
d e canted and
dry.

The re sultanl aqueous -acetone supernatant was

discarded and lhe tubes inverled and allowed to

Drying was usually co n1.pl e te in 30 - 40 minutes .

The
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precipitate was resuspended in 1. 0 ml of 0. 2N H

2

so4

by mixing in a

Vortex mixer for 10 seconds, and th e tub e s were allo we d to stand at
room t e mperature for 2 0 minutes.

The tubes were then centrifuged

at 10, 000 x g for 10 minutes and the resultant superna tant was car e fully
decanted into another set of Nalgene tubes.

After the addition of 5 ml

of cold acetone, the tubes were mixed by inversion, as before, and
allowed to stand in a freezer for approximately 30 minutes.

The tubes

were centrifu ge d for 10 :minute s at 10, 000 x g and the supe rnatant
discarded.

One ml of O. 05 M barbital buffer, 7. 5 Min ur ea (pH 9. 0),

was added to the precipi tate and mixed on a Vortex mixer for 10 s ec onds.
The tub e s were allo wed to stand at room te m p e ratur e for 15-20 minutes
at which tim e 0. 5 ml of this solution was tr ansfe rr ed to glass cou nting
vials containing 15 ml o f a sci n ti llation cocktai l which was pr epared by
dissolving 4g o f 2-5-diphenyloxazole (PPO) plu s 50 mg of 1,4-phenylene -bio - 2 -(5 -pheny lo xaz ole ) in 700 ml of toluene plu s 300 m l of BBS-3
(Bio-Soiv , Beckman I nstruments , I nc . ).

Th e vial s were counted i n a

Pac kard Tri-Carb Liquid Scinti ll ation Spectrorneter at a counting
efficiency of approximate l y 70 %, as determined by quench correc tion
s eries .

F.

PROTEIN DETERMINATION
Pro te i n content of whol e

hon~ogenate ,

subcellular fractions and

10, 000 ·x g supernatant was d elcrnunc<l by the inethod of Lowry et a l.
(19 5 1).

A 0. 2 ml sample of the fraction to b e as sa ye<l was ad<le<l to
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tubes containing 0. 8 ml of 0. 5N NaOH.

Prote in standards at concen-

trations of 0. 5, 1. 0 and 1. 5 mg/ml were pr e pared using bovine plasma
albumin (Calbiochem).

Reagent blanks containing 0. 2 ml of Robinson's

m e dia were treate d identically as tissue samples.

The tub es were

stoppered and placed in a hot water bath for 1 hour maintained at
70-75°C.

The samples were cooled by imme rsion in cold tap water .

A

0. 2 ml aliquot of the boiled sample was add ed to 0. 8 ml of 0. 5N NaOH
a

and 5. 0 ml of Reagent A .

The sample s were mixed on a Vortex mixer

and allo wed to stand for 20 minutes at room tempe rature.
this, 0. 5 ml of Reag e nt B

b

Following

was added to each sample, mi xed

immedi a t e ly and allo wed to st and at room t emp e ratur e for
until color development was complete .

40 minutes ,

The absorbance at 500 nm was

re a d against the r eagent blank o n a Beckman DB -Spectrophotometer
(Beckman Instruments ).

G.

EXTRACTION OF NUCLEIC ACIDS
Th e method of S chneider ( 1945 ) for the extraction of nucleic acids

and th e measurement of DNA was used.

aReagent A: 2. 5 m l of a 2. 7% (w / v) potassium. tartrate solution
and 2. 5 ml of a 1. 0% (w /v) coppe r sulfate added to 2 5 0 ml of 2 . 0 %
(\v /v) sodium carbonate solution.
bReagent B: Conunercial folin-phc nol reagenl dilute d to IN
with distilled water.
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A 0. 7 ml aliquot of a 10 percent rat uterine whole homogenate was
mixed (Vortex) with 2. 5 ml cold 10 percent trichloracetic acid (TCA) in
15 ml Corex glass tube and centrifuged in an IEC Clinical Centrifuge at
1000

RPM for six minutes.

The supernatant was decanted and discarded

and the precipitate resuspended in 2. 5 ml of cold 10 percent TCA.

The

tubes were centrifuged as above, and the supernatant was decanted and
discard e d.

This procedure is used to remove acid-soluble phosphorus

compounds.
The tissue residue was suspended in 1. 0 ml of distilled water by
Vortex mix for 10 seconds, and 4 . 0 ml of 95 percent ethyl alcohol and
centrifug ed .

The supernatant was decanted and discarded, and the

residu e was r e suspende d in 5. 0 ml of 95 percent ETOH.
n a tant was decanted and discarded.

The super-

Thes e steps are used to remove

traces of TCA from the r esidue .
The tissue residue was boiled 3 tim es for 3 ininutes each with 5 . 0
ml portions of an alcohol-ether mixture (3:1).

A small boiling chip was

added to each tube in ord e r to facilitate even boiling.

The tubes were

centrifuged as before following each boiling and the supernatant was
decanted and discarded.

This procedure was employed to remove phos -

pholipi ds .
The ti ssue residue was suspe nded in 1. 3 ml of distilled . water
nri xed with 1. 3 ml cold 10 percent TCA and centrifuged.
was decanted and discarded.

The supcrnate
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The tissue residue was resuspended in 5. 0 ml of 5 percent TCA,
and the tubes were h e ated for 15 minutes in a water bath at 90°c.

The

tubes were centrifuged and the supe rnatant was decanted and saved.
The tissue residue was resuspended ir{ 2. 5 ml of 5 p e rcent TCA
and centrifuge d.

The TCA extracts we re combined (7. 5 ml) to form

the nucleic acid extract.

H.

ESTIMATION OF DNA
One ml of the nucleic acid extract was mixed with 2. 0 mi of

diphenylamine reagenta and heated in a boiling water bath for 10 minutes
at 90°C.

The intensity of blue color wa s r ea d at 600 nm .

DNA standard solution·s were prepar ed in concentrations ranging
from 20pg/ml to 200pg/ml by dissolving 10 mg of highly polymerized
DNA in 25 ml of 5 p ercent TCA, and diluti ng to the desired concentrations .

I.

A reag ent blank of 5 percent TCA was us ed .

ESTIMATION OF RNA
The method of Ceriotti (1955) "\va s us ed for the measurement of

RNA.

1' ive ml of the nucleic extract was added to 5 . 0 ml of freshly

prepared orcinol reagentb

~n

15 rn.l screw-cap tubes.

The samples were

aDipheny1amine Reagent: 1 gn.1. of diphenylamine which is recrystalli zed in boiling hexane is dissolved in 100 ml of glacial acetic acid
(analytical reagent) and 2. 75 ml of reagent concentrated sulfuric acid is
added .
bor cinol Reagent: 200 mg of purified orcinol is dissolved in con centrated HCL, add 10 ml of CuCL2 reagent (0. 00..f.M CuCL2 in concentr ated HCL: 68. 2 mg CuCL2/lOO ml HCL ) and make up to 100 ml with
concentrated HCL.
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mixed thoroughly and the tubes placed in a boiling water bath for 40
minutes.

After cooling 'yVith running water , the color was extracted into

5. 0 ml of isoamyl alcohol with shaking (B uchler Instrume nts, New Jersey).
The tubes were centrifuged and a 3. 0 ml aliquot of the isoamyl alcohol
layer, containing the chromophor, was pipetted into an additional series
of tub es.

The absorbance at 675 nm was determined.

RNA standard

solutions were prepared by dissolving RNA in 5 p e rcent TCA over low
heat.

The isoamyl alcohol layer t aken from the tube containing no RNA

was used as the blank.
J.

STATIS TICAL METHODS
The 2-tailed

students

"t'' t est for inde p endent means , calculated

on an Olive tti Underw ood Programma 101 desk computer, was used to
t est for differences between means.

The formula employed is as

follo ws :
X1 - X2
t= - - - - - - - sp (1/N 1 ) + (1 /N2)

where :

s p2 =

(N l - 1 )S l

Nl

2

+

(N 2 -1 )S 2

+ N2 - 2

Co ntrol sample siz e

N1

-·

N2
2

= Tr eated

sample size

= Control

sample variance

s1

2

2

= Tr eated

sample variance

X1

= Control

sa1nple m e an

X2

= Treated

sample rnean

S2

The degrees of freedom. '''er e taken as N 1 + N2 - 2.

The l evel

of significance (P) was det e rrr1ined by con1parison of "t" with value.:>
from standard t ables .

IV.

RESULTS

The 10, 000 x g supernatant fraction of rat ut erine tissue was
employed as th e hi stone acetylating system throughout the study
(Appendix A and B).
Various concentrations of methylglyoxal and phenylglyoxal were
preincubated in a standard assay system for 15 minutes .

His tone was

added and the r eac tion was allowed to proce ed for an additional 30
minutes .

Under these conditions, as shown in Fi gure 1, both phenyl-

glyoxal and methylglyoxal inhibit ed in vitro his ton e acetylation in a
conc entrati on dependent manner .

Drug conc ent rations of 2 x 10- 4 M to

3
1 x l0- M depressed in vitro histone acetylation approximately 25
p e rc ent to 75 p e rcent, respectively (Figur e 1).

The 150 for methyl -

glyoxal wa s 0. 5 mM, and 0. 4mM for phenylglyoxal (Tabl e 1).
The in vitro effect of i ncubating phenylglyoxal with the uterine
his tone acetylation preparation prior to assay is shown in Table 2.
Following a 10 rninute incubation p e riod, an aliquot of the preincub a tion
systen1 containing enzyn1e and drug was introduced into a standard
assay system .

The reaction was allo wed to proce ed for 20 minutes .

Under th ese co ndi tions, appro xima tely 80 percent inhibition was
achiev e d at 5 x io- 4 M as say system concentration, b e low which l evel
no significant degree of enzyrne inhibition wa.s not ed .

The results of a

parallel study, designed to d eterr:nine the effect of phenylglyoxal
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Figur e 1:

Effect of (a ) phcnylg lyoxal and (b ) methylglyoxal o n
in vitro histone acetylation by a cell-free rat uterine
syste1n . ·Freshly prepared solutions of glyoxals were
added at various concentrations and preincubatcd for
15 minutes at 37°C prior to the addition of his tone .
The r eac lion was a llowed to p roceed for an addilional
30 minutes . Each point represents at l east thr ee
d e t e rmin a tions.
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Table 1.

Inhibition of in vitro histone acetylation by glyoxal derivatives :
I ndex of inhibition (I
value)a
50

C ompound

I so Value

Me thylglyoxal

0. 5mM

Phenylglyoxal

0 . 4mM

a The approximate concentration of drug at
which 50 percent inhibition is observed .
Various concentrations of inhibitors were
preincubat e d for 15 min at 37°C prior to
addition of 1 mg calf thymus his tone .
The data was plotted and I 50 values
graphically determined.
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Table 2.

In vitro inhibition of histone acetylation:
glyo xal-e nz yme pr e incubation

Phenyl g lyo xal Concentrati on (F inal)
Preincub a tion
Syst em a

Assay
b
System

Histone Acetylation
dpm/mg Histone
+ S. E.""
Mean_
J,

5 . 0 x lo -4M

5 . 0 x lo -SM
5. 0 x 10- 5 M

a

b

Perc en t
Inhibition.

+

300

4, 902 +
-

591

78

20,117 +
- 1521

10

22, 317 +
- 1011

0

22, 140
5 . 0 x lo -3M

Effect of phenyl-

control

Phen ylglyo xal s olu tions of appr op riate ·concentrations were incubated
with 0. 25 ml aliquots of 10, 000 x g rat ute rine supernatant fraction
at 37°c for 10 min with shaking .
Follo wing pr eincubation (a ), a 0. 1 ml aliquot of th e phenylglyoxalenzym.e mixture (equival ent to 0. 05 ml supernatant ) was added to
tu bes containing 0. 9 ml of standard assay system components , l ess
su p e rnatant . Th e cornpleted system was then incubated at 37°C ,
with shaking, for 20 min .

>!<Mean~

S. E . of triplicate determinations .
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incubation with histone are presented in Table 3 .

In this study, a

S x lo- 4 M phenylglyo xal assay system concentration inhibited in vitro
his tone acetylation by approximately 30 percent.

Inhibition of his tone

acetylation was not evident at a concentrati~n of S x 10-6M phenylglyoxal.
The effect of gl yoxals on uterine weight and total body weight
gains in immatur e rats was explored by administering daily injections
of me thyl g lyoxal-bis -guanylhydrazone (Methyl-GAG , 20 mg /kg , intrape ritoneally ) and glyo xal monohydrate (200 mg/kg, intrape ritoneally)
for six days .

The incr ea se in total body we ight over the six day

treat me n t period was also studi e d.
in Table 4.

R e sults of this study are presen ted

A nimals r e ceivin g glyo xa l monohydrate gained signifi-

cantly l es s weight (P <.. 0. OS) than di d the contro l animals.

Uterine

wet weight of g lyo xa l tr ea t e d animals wa s appro x imate l y SO p e r cent of
vehicl e tr eat ed controls.

Thi s a lte r ati o n was r e fl ected when th e d at a

was expressed as uterine /b ody we i ght ratio.

This v a lue was em.ployed

to account for v ar iation in tis sue weight that may b e due to body weight
diffe r ences i n animals fro1n any experimenta l group .

No diffe rence

(P ) 0. 05) in net body we i ght gain was observed i n animals r ece i ving
M ethyl-G AG , 20 mg/kg , i ntraperitoneally , fo r si x days when comp ared to contro l s.

Howeve r, uterine \\·et weight of Methyl-GA G treated

ani1nals was d epressed (P

<0. 025),

not e d in the glyoxal t1·eated group.

but to an extent l ess th an th at
This alteration '-.Vas also r eflected
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Table 3.

In vitro inhibition of his tone acetylation:
glyoxal-histone preincubation

Phenylgly o xal Concentration (Final)
Preincubation
System a

Assay
Systemb

Effect of phenyl-

Histone Acetylation
dpm/mg Histone
Mean± S. E. "~

5.0 x lo- 3 M

4
5. 0 x 10- M

18, 303

± 3666
±4378

5.0 x l0- 4 M

5
5. 0 x l0- M

22, 700

± 1255

5.0 x 10-5M

5. 0 x 10- 6 M

2 6' 7 40 + 1691

26, 553

Percent
Inhibition
control
32
15
0

aO. 6 ml his tone solution (10 mg/ml) was added to 0. 6 ml of phenylglyoxal solution of various concentrations, or 0. 6 ml of phenylglyoxal
v ehicle (phosphate buffer) for control as says and the mixture was
incubated with shaking for 10 min at 37°C.
bFollo wing pr e incubation period, a 0. 2 ml aliquot of phenylglyoxalhistone mixture (equival ent to 1 mg histone) was added to lub es
containing 0. 8 ml of standard assay system components, less
histone. The complete system was then incubate d at 37°C for an
additional 20 min.
>:<Mean

±S. E.

of triplicate determinations.
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Table 4.

Effect of glyoxal derivatives on body we ight and uterine wet
weight in imma ture female rats

Treatmenta

Body Weightb
Increas e (gm)

Ute rine W e t
W e ight (mg)

M e an± S. E. (N)

M e an± S. E. (N)

± 3. 1

(5)

Control

34. 4

Glyo xa l

21.2 ~ 3.6 (4)
(P < . 05 )'~

Methyl-GAG

±

32. 0
2. 9 (5)
(P) .05) *

152

± 15

68 ±

Uterine /Body
Ratio (%)
Mean± S. E. (N)

(5)

0.140

5 (4)

0. 065

J,

(P

< . 001r

107
(P

±

<

8 (5)
. 025) '"
J,

(P

±. 01 4 (5)

± . 00 4 (4 )
< . 0025)"'"'

0. 092 ~ . 008 (5)
"'
(P < . 01) "'

aCo n trol: 1 ml/kg, i. p., 0. SM phosphate buffer (pH 7 . 4) daily for 6
days;
Glyoxal: 200 mg/kg , i. p.; and Methylglyoxal-bis-guanylhydra zone (Methyl -GAG), 200 n1g/kg, i. p., daily for 6 days .
bM ean body we ight gain during 6 day experimenta l period.
"'
"'Determined by Student

''t" t est.
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in the uterine/body w e ight ratio, indicating that the alteration was not
due to inherent tissue weight differences attributable to variations in
total body weight alone.
In order to determine the effect of prior glyoxal treatment in
animals receiving estradiol alone, several groups of rats were given
daily injections of glyo x al, 200 mg/kg, intraperitoneally, or MethylGAG, 20 mg/kg, intraperitoneally, for six days.

In addition,

estradiol 12 pg/rat was administered subcut ane ously every 12 hours
for 60 hours beginning day thr ee of treatme n t.

The comparison of

effect of estradiol alone or in animals pretreate d with glyoxals is
presente d in Table 5.

Uterine /body weig ht r a tios of animals rec e iving

either glyoxal or Methyl-GAG .prior to estradiol administration were
significantly lo wer (P ( 0. 005) than were compa rable values obtai ne d
from anirnals r ece i ving es tr adi ol alone.

No si gnificant differences

were obs erved in the li ver /bo cly weight ratio of anirn.a l s r eceiving
estradiol alone or in combination with either g lyo xa l or Methyl-GAG.
The early effect of estra<lio l administration on histone ace tyl ation
activity i n i mrnat.ure r at uterus was explored by sacrificing grou p s of
hor mone treated anir11.al s at 0, 5, 10 an d 15 minutes follo\ving inj ection
of estradiol , 12 µ g/rat , subcutaneously.

Th e soluble uterine histone

ac e tyl a lio n fraclion was subsequently p re par e d (as d esc rib e d previous ly)
and the enzyme activi t y determined (Fi gure 2).

In addition , a second

s e ries of anima l s rec eive d phenyl g l yoxa l, 250 mg/kg , intraper itoneally,

1 hour prior to estradiol ad1ninistration , in order t o d ete r rnine the

37

Table 5.

Effect of combined glyoxal and Methyl-GAG with estradiol
administration on uterus /body ratio and liver /body ratio
in immature female r a ts: Comparison betwee n glyo xal
pretreated and estradiol treated animals

Uterus /Body Ratio(%)
Treatmenta

Mean~ S. E. (N)

Liver /Body Ratio( %)
Mean± S. E. (N)

Estradiol-17-C?

0. 197 ~

o. 006

(5)

5.51:0.21(5)

Glyoxal plus
Estradiol

o. 104 ± 0. 006

(5)

6. 17

±

Methyl-GAG plus
Estradiol

0. 147 ± 0. 010 (5)
(P
005) >:'

5. 09

± 0. 35

(P(.005)*

<.

0. 29 (5)
(P> .05) *

(P

(5)

> . 05 )>:'

aEstradiol-17-0: 10 pg/r a t, sub. Q., every 12 hrs for 60 hr s
beginni ng day 3 of experimental period; Glyo xal monohydrate,
200 mg/ kg , i. p. d a ily for 6 d a ys plus estradiol, 10 p.g/rat ever y 12
hrs for 60 hr s beginning day 3 of experimental period; Methylglyoxal-bis-guanylhydra z o ne (Meth yl-GAG ), 20 mg/kg , i. p., daily
for 6 days, plus es trad i ol, 12 p g /rat ever y 12 hrs for 60 hrs
b egi nni ng day 3 of experimental p e riod.
J,

"''Determine d by Student

' ' t" t est.
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Figure 2:

Hi stone acetylation in soluble uterine fraction fro1n
r ats treated with cstradiol alone and in combination
with phcnylglyoxal. Rats were administered eilher
1 ml/kg of 0 . 05M phosphate buffer vehicle (0);
estracliol, 12 µg/rat , sub--Q, (0--0); or phenylglyoxal,
250 mk/kg, i. p., for 1 hour follo\.vcd by estradiol
(~ ) .
Rats we re killed at th e tirn.e i ntcrvals
indicated and soluble uterin e enzyme activity measured.
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effect of phenylglyoxal pretreatment on any early hormone-mediated
alterations in uterine his tone acetylation.
nificantly depressed (P

<. . 05)

following estradiol treatment.

Enzyme activity was sig-

when measured 10 and 15 minutes
A further decrease in enzyme activity

was noted in animals pretreated with phenylglyoxal one hour prior to
estradiol administration.

The differences seen with estradiol treat-

ment alone were significantly different (P

< 0. 05) from phenylglyoxal

pretreated animals given estradiol for 15 minutes.
The in vivo effect of estradiol on uterine wet weight and his tone
acetylation in immature female rats was monitored at 1, 2, 4, 8, 16,
and 24 hours following hormone treatment.

In addition, a parallel

study was performed using phenylglyoxal, 250 mg/kg, intraperitoneally,
in order to determine the time course of the early phenylglyoxal
mediated decrease in uterine his tone acetylation noted in the previous
study.

The alterations in histone acetylation activity following

estradiol and phenylglyoxal administration are presented in Figure 3.
A very rapid estradiol mediated decrease in the ability of the uterine
enzyme preparation to acetylate his tone was found to occur following
hormone administration.

Enzyme activity remained almost completely

depressed until 8 hours after estradiol administration , when enzyme
activity began to increase during an 8 to 12 hour period.

During 16 to

24 hours, the initial effect of the honnone was reversed, so that at 24
hours post estradiol, enz ym.e activity was increased to 135 percent of
control.
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F i gure 3 : Alteration of histone acetyl ation by estradiol and phcny lglyoxal. Each point represents the mean of at l east
.,..
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anima l s . Enzyme activity of control animals is expressed
a s Dpm / mg protein/30 min. (()--0 ) cstradiol , 10 pg/ rat ,
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Enzyme activity response to phenylglyoxal administration closely
follow e d the response seen with estradiol.

Uterine enzyme activity

decr eased rapidly, although not as marke dly as note d follo w ing
estradiol treatment.

Reversal of . th e phe nylglyoxal mediated depress-

ion in enzyme activity began 4 to 8 hours following drug administration.
However, enzyme activity had not returned to control l evels 24 hours
after phenyl glyox al.

A significant (P

<0. 05)

ele va tion in uterine wet

weight was se en tw o hours after estradiol administration.

The initial,

rapid el evation was followed by a s e cond but less drama t ic one which
beg an at about 6 hour s after hormone tre a tment.

At 24 hours, ut erine

wet we ight was elevated to app ro ximat e l y 18 0 p e r cent of control.
Uterin e we t we i ght of phenylglyo xal trea t e d anim als did not change
signific an tly (P) 0. 0 5 ) from control values wh en the p aramete r was
mea sure d o ve r the 2 4 hour p er iod following dru g admi nistration
(Figure 4) .
H a ving determined th e time course of es tr adio l and phenylglyoxal
activity, it was of interest t o determine whether the g lyo xa l s , methylglyoxal and phenylglyoxal, we r e cap a ble of alter i ng th e e l evation i n
uterin e histone ace t yl ation and wet we i ght which h a d been observed 24
hom sfollowing estradiol tre atmen t.
estradiol v ehide
intraperitoneally)

At 20 hours following e ither

or hormo ne treatrnent , (es tradiol, 10 p g /r at ,
groups of ani1nals rec e ive d either methylglyoxal,

phenyl glyoxal or a pho spha te b uffe r vehicle .

All anirna l s we r e
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sacrificed 24 hours following estradiol treatment.

Data presented in

Table 6 indicate that estradiol-17 - ("-> administration causes a rapid
inc r ease above controls in uterine wet weight (P
following hormone administration .
s ignificantly (P )

< 0. 0025) ,

24 hours

Uterine wet weight did not change

0. 05) fr o m control level when measured 4 hours

·

fo ll o wing methylglyoxal administration at either of the doses used in
this study.

Weight of uterine tissue obtained from animals treated

with estradiol and subsequently with methylglyoxal was elevated above
that for v e hicle treated controls.

Similar results we re obtained with

phenylglyoxa l (Table 7).
Th e effect of hormone treatment alone and in combination with
eithe r methylglyoxal or phenyl g lyoxal at two dose levels is shown in
Tables 6 and 7 resp e ctively .

When measured in vitro follo w ing 24

hour estradiol tr ea tment , en z yme activity was significantly (P( 0 . 0005)
elevated ab ove co nt rol values.

Elevation of uterine enzyme activity 24

hours foJlowing est radiol was more pro nounced in this study than the
increas e reported in the estradiol time course study.

Variation in

both the age of the animals (25 day old versus 30 day old rats) and
changes in the brand and prep aration of the estradiol solution inay
account for the ob served differences.
M e thylglyoxal at both dose leve l s depressed enz yme activity
when this p arameter was n1casnred 4hours after glyoxal ad1ninistralion
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Table 6.

Effect of methylglyoxal treatment on uterine weight and
his tone acetylation in untr eated and estradiol pr e treated
rats

Uterine Wet Weight (mg)
Mean ± S. E. (N}
Tr ea tmenta

± 12

.. b
E nzyme A ch v1ty
dpm/mg Protein/ 30 min
Mean± S. E. (N)

± 1071

Control

104

Est radiol-17- ~

1 78 ~ 11 (8)
(P ~ . 0025)':<

Methylglyoxal
125 mg/kg, i.p.

98
(P )

(7)
. 05) ,."

8, 033
1291 (7)
(P( .025) *

M e thyl glyoxal
250 mg/kg, i. p.

104±11(7}
(P) .05)':'

8, 947 ± 877 (7 )
(P< .025) *

Estradiol plus
M e thylglyoxal
125 mg/kg , i. p.

149
(P (

± 11

5, 022 ~ 693 (7)
(P < . 0005)>:'

Es tradiol plu s
Me thylglyoxal
2?0 mg/kg, i.p.

172± 9(8}
(P( .000 5),;'

(6)

± 11

(7)
. 01 ) *

12, 582

(6 )

26,209 ~ 3056 (8 )
(P
0005) *

<.

±

6,666~
(P

717(8}
J,

< . 0005) ,,-

a
Co ntrol : 0. 2 ml estI·adiol vehicle followed by 1 ml/kg 0. 0 5M phos phate buffer (vehicle) , i. p. 20 hrs after ; Estradiol : 0. 2 ml
(lOµ g}/ rat, i.p;
Methylglyoxal: 12 5 mg/kg, i.p . (or 250 mg/kg,
i. p.) administered 20 hrs follov.ring estradiol vehicle ; Estradiol plus
Methylglyo xal : es tradiol , 10 p.g /rat, i. p. follow ed by methylglyoxal
125 mg/kg , i. p. (or 250 rn.g/kg, i. p. ) 20 hrs after estradiol administr ation . All animals \Vere sacrificed 2 4 hrs follo\ving estradiol
admi nis tr a ti on (4 hrs follo"vi ng me thylgl yoxal administration }.
bEnzymc acti\rity is expressed as the Mean ±S . E. of the amount (dpm. )
of 14 C-acetate incorporated his tone formed p er m.g uterine protein
(10, 000 x g supe r natant ) per 30 min.
...-·--

D etennined by Student "t'' t est.
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Table 7.

.

Effect of phenylglyoxa l tr ea tme nt on uterine weight and
histone acetylation in untreated and estradiol pretr eat e d
rats

Treatment

a

Uterine Wet Weight (mg )
Mean± S. E. (N )

Enzyme Activityb
dpm/mg Prote in/ 30 min
Mean= S. E. (N)

± 1071

Control

104 ~ 12 (6)

Estradiol-17-0

178
11 (8)
(P< .00 25) *

Phenylglyoxal
125 mg/kg , i. p.

116 ± 8 (10)
(P) .0 5)*

8,21 5
1153 (10)
(P
0125)*

Phenylglyo x al
250 mg/kg, i. p.

109 = 15 (6 )
(P ) . 05)

7, 123 ± 101 6 (6)
(P < . 01)

Est radi ol plus
Phenylglyoxal
250 mg/kg , i. p.

1 77 ± 13 ( 10)
(P < . 002 5 ) *

7, 638
796 (10 )
(P < .0 025) >:'

a

±

*

12, 582

(6)

26, 209 ~ 3056 (8)
(P ( . 0005)>:'

±
<.

*

±

Control : 0. 2 ml estradiol vehicle follo wed b y 1 ml/kg 0 . 0 5M phos phate buffer (vehicle ), i. p. 20 hrs after; Estradiol: 0. 2 ml
(10 p g )/ rat , i. p.; Phenylglyoxal : 12 5 mg/kg , i. p. (or 250 mg/kg ,
i. p .) administer ed 20 hrs following estradiol vehicle ; Estradiol plus
Phen ylglyo xal: e stradiol , 10 p g / rat , i. p. follo we d by phenylglyoxal
250 mg / kg , i. p., 20 h rs after estradiol administration. All animals
were sacrificed 24 hrs follo wing estracliol administration (4 hrs
following phenylglyoxal administration).

b Enzyme activity is expressed as the Mcan±S. E . of th e amount (dpm )
of 1 4c-acetate i ncorporated histone fanned p er mg uterine protein
(10, 000 x g supernatant) per 30 min .
Determine d by Stud ent

11

t"

test.
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(Table 6).

Similarly, phenylglyoxal treated groups showed lower

uterine enzyme activity when measured at the 4 hour interval (Table
7).

The glyoxal mediated depression in enzyme activity was also

apparent in animals who had received estradiol 20 hours prior to
either methylglyoxal or phenylglyoxal (Tables 6 and 7).

Elevations in

uterine histone acetylation seen 24 hours following estradiol alone
were not seen in animals receiving estradiol followed by either
glyoxal.

Drug induced alterations in uterine hi stone acetylation: are

presented in Figure 5 and 6.
A dose response comparison of the effects of the glyoxals on
enzyme activity and uterine wet weight is given in Table

8~

The

depression of histone acetylation by methylglyoxal and phenylglyoxa l
administe red at 12 5 mg /kg was not significantly different frorn r esults
obtained at the 250 mg /kg dose level.

Similarly, there was no differ -

ence b etwee n dose level s of either drug on uterine 'vveight of g lyoxal
treated animals.
·The data presented in Table 9 indicate that methylglyoxal and
phenylglyoxa l adminis t ere d to anirn.a ls pretreated with estradiol for 20
hours significantly altered the estradio l mediated elevation of uterine
histone acetylation activity seen at 24 hours in animals r ece iving
estradiol alone.

Neither methylglyoxa l nor phe nylglyoxal significantly

altered the estradiol inediate d increase in uterine weight.
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Figure 5: Alteration of his tone acetylation in rat uterus by
estradiol and methylglyoxal, expressed as percent
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Table 8.

Cornpari son of alterations in uterine his to ne acetylation and
uterine we t we ight at t wo dose leve ls of rne thylglyoxal and
ph enylglyoxal

Treatme nta

Uterine Wet Weight (mg )
Mean± S. E. (N)

Enzyrn.e Activityb
dpm/rng Prote in/3 0 m_j_ n
Mean -: S. E. (N)

Methyl gly o xal
125 mg/kg
250 mg/kg

± 11
104 ± 11

8, 033 ~ 1291 (7)

98

±

871 (7)
8, 94 7
(P ) . 05) ,:'

(P) . 05) *

Phenyl gl yoxal

a
b

±8

125 mg/kg

11 6

250 mg/kg

109 ~ 15
(P) .0 5 )*

The glyoxals we re adminis t e r e d, i. p.

8,215 ~ 115 3 ( 10)

±

7, 12 3
101 6 ( 6)
(P ) . 0 5 )*

4 hrs prior to sacrifice.

±s.

Enzy me activity i s expressed as th e Mean
E . of the amount (dpm )
of 14c - acetate incorporat e d hi s ton e forn~ed p e r rng uterine p ro t e i n
(10, 000 x g su pe r natant ) p e r 30 min.

~~

D e t e r mine d by Stu dent

' ' t" t es t.
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Table 9.

Effec t of me thylglyoxa l and phenyl g lyoxa l tr eatment on the
estradiol mediated stimulation of histone ac et ylation and
uterine weight.

Uterine W e t Weight (mg )
Mean± S.E. (N)

Treatmenta
Es tradi ol-1 7 -

(?

178

± 11

Enzyme Activityb
dpm/mg Protein/30 min
Mean± S. E. (N)
26, 209

± 3056

(8 )

Estradiol plu s
Me thyl glyoxal
125 mg/kg, i. p.

149 ~ 11
(P ) . 05) *

5, 022 ~ 639 (7)
(P < . 0005) >:<

Estradiol plus
M ethylglyoxal
250 mg/kg, i. p.

172
9
(P).05) *

±

6,6 66: 717(8)
(P < . 00 05 ) *

Est radiol plus
Phenylglyo x al
250 mg/kg, i. p.

177
(P )

a

± 13
. 05 )>:<

..L

7,6 38:.. 791 (10)
(P < .0 005)>:<

Estr adiol : O. 2 ml (10 p g )/r at , i. p.; Estra<liol plus M e thylglyoxal:
estradiol, 10 ng/r at , i. p. foll o wed by met:hylglyoxal , 125 mg/kg ,
i. p. (or 250 mg/kg, i. p.) 20 hrs after estradiol administration;
Estradiol plus Phenyl g lyoxal: estradiol , l O p g/rat, i . p. , follow ed by
phenylglyoxal , 250 mg/kg , i. p . 20 hrs after estradiol. All animals
were sacrificed 24 hrs following estradiol ad1ninistralion (4 hrs
follo wing administration of either glyoxal) .

bEn zyme activity i s expressed as the Mean -t S. E . of the amount (dpm )
of 14 C - acetatc incorporat ed his tone forn1e<l per mg utc rine prot e in
(10, 000 x g supernatant) p er 30 min.
Dete rnuned by Student

11

t 11 t e st.
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Table 10 shows the effect of phenylglyoxal, 125 mg/kg,
administered 4 hours prior to sacrifice, on uterine weight total DNA,
RNA/DNA ratio and protein/DNA ratio.

DNA was employed as a

baseline in this and parallel studies because, unlike uterine RNA and
protein, its concentration remains relatively constant during growth
changes and alterations in hormonal environment.

When compared to

vehicle treated controls, uterine tis sue obtained from animals treated
for 4 hours v.'1.th phenylglyoxal did not differ significantly in the
various parameters monitored in this study.
Uterine wet weight, total DNA, RNA and protein were measured,
and the uterine/body, RNA/DNA and protein/DNA ratios were determin ed in animals treated with phenylglyoxal alone and in combinations
wilh estradiol.

In this study, animals rec eive d ph e nyl glyoxal, 125

mg/kg , intraperit oneally, d a ily for two days.

A single inj e ction of

estradiol, 10 }.lg/rat, intrape rito nea lly, was administered to rats
which had received only phosphat e buffer vehicle for two d ays .

A

second group of rats which had rec eived phenylglyoxal for two days
also received a single inj ection of estradiol.

All groups were sacri-

ficed 24 hours following estradiol treatme nt and subsequenl det ermination s were performed on the excised uterine .tissu e .

The data

pres ented in Table 11 indic ate tha t estradiol given alone e l evated
uteri ne wet \veight, where as p henylg lyo xa l administered for 2 days
did not significantly alter this parameter.

The ute rine '\veight of

<"

Table 10.

Effect of 4 hour phenylglyoxal treatment on wet weight and nucleic acid content in the
immature rat p.terus

Ute rine Wet
Weight (mg)
Mean ± S. E. (N)

Treatment
Control

a

Phe nylglyoxal

a

b

Uterine /Body
R a tio (%)
Mean± S. E. {N )

± . 005

53±5(12)

0 . 079

(12)

5'4 ':'.: 4 ( 12)
(P) . 05) :1~

0.082 ± .006 (12)
(P ) . 05) *

Total DNA
RNA
Protein
DNA
DNA
Pooled Uteri (mg)
Mean± S. E. (N) Mean ±S.E. (N) Mean± S.E. (N)
. 94

± . 07

(5)

.83 ± .07 (5)
(P ) . 0 5)*

.508

10. 7

. 497
(P
05)"'

>.

J,

13. 9
(P
o5t

>.

Control: vehicle, 1 ml/kg, i. p. of 0. 05M phosphate buffer (pH 7. 4) administered 4 hours prior to
sacrifice .

bPhenylglyoxal:

dissolved in vehicle and administered 4 h ours prior to sacrifice, 125 mg/kg, i. p.

,.,
' D e ternuned by S tud e nt

11

t 11 test.

\.11

N
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Table 11.

Effect of 48 hour phenylglyo xal pretr ea tment on estradiolmediated alterations in immature r at uterus

Treatmenta

Ute rine Wet Weight (mg )
Mean± S. E. (N)
62

Control
Estr adi ol

+ 12

182

"i:

(P

<

(12)

12 (12)
. 001) *

Pheny lglyoxal
plus es tr adi ol

98 ~ 7 (10)
(P < . 005)*

Pheny lglyoxal

51 ~ 4 (10)
(P ) . 05)

*

Ute rus /Body Ratio (%)
M e an~ S. E. (N)
. 082 ~ . 009 (12)
27
(P

~. 002 (12)

< .001) *

17~.0l
(P {

(10)

. 001) *

.092 ~ .0 04 (10)
(P > . 0 5)*

a

Co ntrol : v e}li cle, 1 ml/kg, i. p. of 0. 05M phosphate buffer (pH 7. 4)
ad ministered once daily for 2 days; Estradiol-17-(?; lOµg/rat,
i. p. administered 24 hrs prior to sacrifice; Fhenylglyoxal plllS
E stradiol : 125 mg/kg , i. p. administered daily for 2 days , plus
estradiol , 10 ).lg/r at , singl e inj e ction on day 2 of treat1nent.
Animals were sacrificed 24 hrs following es tradiol; Phenylgl yoxa l:
12 5 mg/kg , i. p. administered daily for 2 days . Animals were
sacrificed 24 hrs following last inj ecti on
>:'Determined by Student

11

t 11 test.
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animals pretreated with phenylglyoxal for two days, and then give n
estradiol was significantly elevated above vehicle treated controls.
These alterations were also reflected in the uterine/body weight
ratio.

As noted in Table 12, total DNA, RNA/DNA ratio, and

protein/DNA ratio we re significantly elevated in uterine tis sue
obtained from estradiol treated animals.

Measurement of these

paran1eters in uterine tissue of phe nylglyo xa l treated animals indicate
that total DNA was not altered, whereas both the RNA/DNA ratio and
protein/DNA ratio were significantly (P
compare d to vehicle treate d controls.

< 0. 005)

decreased as

Th e ut e ri of animals pre-

treat e d with phenyl g lyoxal and then given estradiol contained th e same
total amount of DNA as w as found in vehicle treated controls.
Ho weve r, both the RNA/DNA and protein /DNA ratios we r e elevated
above control values.

In Tabl e 13 a comp arison is made between the

effects of estradiol on the immat ure rat ute rus and th e action of the
hormon e when given to animals who had r ece ived phenylglyoxal for 2
days prior to estradiol ad1ninistration.

Uter ine we t weight in phenyl-

glyoxal pretr eat e d animals was app roxima t e ly 50 p e rcent th a t of
estradiol tr eated animals.

Tota l uterine DNA and the prote i n /D NA

rati o were significantly (P
estradiol t reated group .

< 0. 05)

decre ased when compared to the

The uterine RNA/DNA ratio of estradiol

tr eated anin1als did not differ fron1 val ues obtaine d fron1 the ut erus of
phenyl gl yoxa l pre treated animals r ece iving the hormone .
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Table 12.

Effect of 48 hour phenylglyo xal pretr ea tment on estradiolmedi ated alterations in immature r at uterus

b
DNA .(mg)
Pool ed Uteri
Mean± S. E. (N)

RNA/DNA
Mean± S. E. (N)

Protein/ DNA
Mean± S. E. (N)

Control

0. 86 ± . 06 (5)

0.600±.016 (5)

11.21±0.65 (5)

Estradiol

1.21±.09(6)
. 02) *
(P

o. 82'5 ± . 039
(P < .001) *

(6)

18. 30 ± 1. 18 (6)
(P < . 001) *

Phenylglyoxal
plus estradiol

o. 83

± . 12 (5)
(P) . 05)

0.831
.020 (5)
.
001)
(P <

13.00±0.31 (5)
(P < . 05) -~

Phenylglyoxal

0.77 ± .06 (5)
(P > . 05) *

0. 490 ± . 02.0 (5)
(P < .00 5 ) ~~

7. 78 ± 0. 30 (5 )
(P <. • 005)

Treatmenta

a

<

*

±

J,.

'I'

J,.

*

Co ntr ol: v e hicle , 1 mg /k g , i. p of 0. 05 M phosphate buffer (pH 7. 4)
ad ministered o nce daily for 2 days; Estradiol-17; 10 ug/rat, i. p.
administe red 24 hrs prior to sacrific e ; Ph enylglyoxal plus E s tradiol:
ph cnyl glyoxal , 125 mg/kg , i. p. administered dai ly for 2 days , plus
estradiol, 10 ug/rat, single inj ec tion o n day 2 of tr eatment.
Animals v.:ere sacrific ed 24 hrs follo wing estradiol ; Phenyl g lyo xal:
125 mg/kg , i. p. admi nis t e red o nce daily for 2 days . Anim a l s were
sacrific e d 24 hrs follo wi ng l ast i n j ec tion.

bRepresents Mean
t wo pooled ute ri.

S. E . of tota l DNA content of samples containing

D e termined by Stud ent

"t" t es t.

Table 13.

Effect o f 48 hour phenylglyoxal pretreatn1.ent on e stradiol-mediate<l alterations in the
immature rat uterus : Comparison between hormone treatn1.ent alone and in combin ati on
with phenylglyoxal.

Treatmenta
Estradiol
Es tradiol plus
Phenylglyoxal

Uterine Wet
Weight (mg)
Mean± S . E . (N)

± 12

182
98
(P

±

<.

DNAb
Pooled Uteri
Mean -.t S. E . (N)

·--

RNA
DNA
Mean-~ S. E. (N)

Protein
DNA
Mean ± S. E. {N)

(12)

1.2 ~ .0 9 (6)

. 8 25!.039

18.3 ± 1.2

7 (10)
001 )>:'

. 83± . 12(5)
(P(. 05)

. 83 1 ~ . 02
:1.(P ) . 05) ,,

1 3 . 0±.31
(P( .00 5t

*

aEstradiol -1 7 -(): 10 ug/rat, i.p. administe red 24 hrs prior to sacrifice; Phe.n ylglyoxal: 125 mg/kg,
i. p. administered daily fo r 2 days plus estradiol , 10 p.gh:at, i. p., single injection on day 2 of
treatment . All animals were sacrificed 24 hrs .following est.radio!.
bRepresents Mean± S. E . o f total DNA content of samples containing two pool ed ute ri.
*Determined by Student

"t" test.

l11
O'

V.

DISCUSSION

The in vitro studies of the effect of various ketoaldehydes on
uterine histone acetylation suggest a dose dependent inhibitory action
(Figure 1 ).

The nature of the I50 study (Table 1) makes it difficult to

relate the values for glyoxal concentrations obt ained in this study to
tho se found to be effective in other laboratories.

The I50 value

is

dependent upon the protein content used in the system being analyzed,
in this case, both enzymatic and other cell protein; therefore, the

r 50

value s reported in our study will not necessarily correlate with
similar studies that used a different protein conten t in their assay
systeni.

It is of interest to note , howeve r, that the various glyoxal

derivatives ernployed in several reported studies (Gr egg , 1968;
Kl amerth , 1968; S zent-Gyorgyi, 1968) were active at concentrations
similar to the I 5 o values reported in our studies.

Scaife (1969), using

mM concentrations, obtain ed methylglyoxal and kethoxal mediated in
vitro inhibition of human kidney cell DNA, RNA, and protein synthesis .
Similar conc e ntrations of glyoxal (0. 5mM) are capable of blocking DNA
replication and protein synthesis w:i thout affec ting respiration in hum.an
fibroblast cell cultures (Klamerth, 1968).

In addition, a sharp con-

centr ation effect , evident in the dose respons e study was reported to
occur ...vith methylglyoxal when th e drug was tested for mitotic inhibitory
prope rties (Scaife, 1969).

While a direct correlation between these
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literature reports and the present study is not warranted, it is noteworthy that several studies involving different biological sys terns show
that glyoxal derivatives are effective at similar concentrations.
Although inhibition of in vitro his tone acetylation had been
demonstrated by our previous studies, the mechanism(s) involved in
thes e actions was left undetermined.

Results obtained from the study

of glyoxal mediated inhibition at the incubation level (Tables 2, 3)
sug gest that the major site of action is the uterine acetylation enzyme
system .

However, a direct alteration of his tone protein leading to a

blockade of acetylation must also be considered, since phenylglyoxalhis tone preincubation results in a significant decrease in the in vitro
acetylation of histone protein .

Takahashi

(1968) demonstrated a

blockade of guanido residues in prot ein , which may account in part for
the decrease in his tone acetylation following incub a tion of his tone
protein in th e presence of phen ylglyoxal.
The results of our in vitro studies led to an analysis of the in
vivo effects of the glyoxal derivatives.

According to pres en t concepts

of histone function(s), bloc kade of histone acetylation in vivo might b e
expected to alter normal growth patterns in a biolo gical systeni.

The

rat uterus , which had been employed during our preliminary studies,
was chosen as a model system. in which to study glyoxal action ,
becaus e of the \vell defined growth pattern initiated by horm.onal
stimulati on .

Although an alleration in uterine histone acetylation
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following estracliol treatme nt had not been r e ported in th e lite rature
prior to the i nitiation of these studies, it was our b e li e f that hormone
treatme nt would affect this parameter and th a t hormone-induced
alterations in the tar g e t organ could b e blocked to some e x t ent by the
glyoxals.

Results obtained from our initial in vivo studies indicated

that the t w o glyo xals , M e thyl-GAG and glyo xal monohydrate , depressed
uterin e wet weight (Table 4).

In additi on, elevation of uterine we t

w e ight normally observed in estradiol treated rats was not apparent
in anim a ls receiving estradiol in conjunction wi th the glyoxals (Table
5).

The s e data suggest a glyoxal m ediated blo cka d e of at l east one

p ar ame t e r of es trogen r e spon se .
B e fore any furthe r study involvin g es tradiol , glyoxals, and
ut e rin e histone ace tyl ation c ould b e attempted, i t was necessary to
d e linea t e the action of estradiol on acetyl ation proper ties of the honnon e
stimul ated ute ru s , so th a t we woul d then b e able to eval uate glyoxal
m e diated a lterations of this system more precis e ly.
An initial effect of es_tradiol treatment on th e rat uterine acetylation syste1n was the depression of histone acctylation in this organ
(F i gure 2).

This action was very rapid and r esulted in a depression in

enzyme activity measurab l e as early as 10 ininutes follo"\vi ng hormone
tr eatment .

Our d a ta are not in agreement wi th Libby ( 1 971 ), who

reported a rapid stimulation of histone acetylation i1nn1ediately followi ng estradiol t reatment , peaking at approxiinatcly 15 minutes and
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returning to control levels 20 minutes following estradiol treatment.
However, our results do agree with Anderson and Gorski (1971), who
demonstrated that es tradiol caused an early dee rease in his tone acetylation followed by an increase, beginning at about 18 hours and
elevating to 150 percent of control 24 hours after hormone treatment.
Kaye and She ratzky ( 196 9) have pr evi ously shown a decr ease in the
activity of prot e in (histone) methylase obtained from the centrifuged
(105, 000 x g) supernatant fraction obtained from rat uterus of
estradiol tr eated animals.

The differences in dose schedule, observa-

tion times, and assay procedure may account for th e lack of agreement
of the results of these studies.
Phenylglyoxal, 250 mg/kg, intraperitoneally, decr ease d enzyme
activil y when administered one hour prior to estradiol treatment
(Figure 2).

The mean enzyme activity for phenylglyoxal pretreated

groups r e cci ving es tr adiol t ended to be lo'.ve r than the mean value s of
estradiol treated groups at 0, 5, and 10 minutes follo'vving hormone
trealrnent.

Although not statistically significant (P ) . 05), these

values suggest that a longer pretreatment p e riod might result in a
greate r difference between these groups.
Phenylglyoxal pretreatment, followed by estradiol, significantly
lowered (P

< . 05) hi s ton e

acetylation activit y as compar e d both to

control groupa and to estradicl treate d groups , \<:hen measured 1 5
mi nul e s following e stradiol t.reatnl.enl.

The apparent ear] y inhibitory
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effect upon uterine hi stone acetylation by estradiol was unexpected in
that stimulation of hormonally excitable systems generally results in
an early augmentation of histone acetylation (Allfrey, 1966; Pogo et al.,

1966; Pogo and Allfrey, 1968).
Data presented in Figure 3 indicate that one of the initial effects
mediated by estradiol is a virtually complete inhibition of uterine
his tone acetylation.

The time course of the latter reversal of the

initial inhibition and subsequent stimulation of his tone acetylation to
levels above control may be pertinent when estrogen mediated alterations in uterine RNA and protein content are consid ered .

In the

studi es of Olive r and Kellis ( 1970), RNA (J.lg /mg dry weight ) in the
irnma tur e rat uterus remained r e lative ly constant up to 10 hours after
tr eatment with 5 pg of estradiol.

Elevation of uterine RNA l eve ls

r e portedly occurred between 10 and 12 hours following estradiol ,
whereas uterine DNA (ug/mg dry we ight) decreased during th e same
interval .

Administration of estradi ol to ovariectomized rats resulted

in a measurable elevation i n th e RNA/DNA r atio , co n~menci.ng
appro xirnate ly 8 hours and co ntinuing up to 24 hours after hormone
administration.

Results of the present study suggest that t he

estradiol mediated elevation in ute rine his tone acetylation occurred at
a ti1ne when uterine RNA l eve l s were increasing through the action of
this hormon e .

These findings are in accord \.vith othe r workers \.vho

h ave obs e rved an e l evation in his tone acetylation preceding or
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paralleling rises in RNA and protein in several unrelated syste1ns
(Allfrey. et al., 1963; Pogo~ al., 1966; Pogo et al., 1969).
Measurement of uterine histone acetylation activity following
phenylglyoxal treatment (Figure 3) demonstrated the ability of this drug
to cause a rapid depression in uterine enzyme activity, with peak
depression corresponding to appro x imately 60 percent inhibition 4
hours followi n g phenylglyox al administration.
remaine d depressed up to 24 hours.

Enzyme activity

The effect of both estradiol and

phenylglyoxal on uterine hi stone ac e tylation and alterations in ute rine
wet weight follo we d similar temporal patt e rns during the first 2 hours
of drug activity (Figure 4).
The app a r e nt decrease in ute rine we t weight follo w ing phenylglyoxa l tre atment was not significant (Figure 4), although it is assumed
from th e r esults pr esented in Table 1 th a t m ore p ro longed adminis tration of ph e nylglyoxal would most like ly d epress uterine we t weight.
The rapid e l evation in uterine wet weigh t following estradio l adrninis tratio n to i mmature female r a ts is we ll ch arac t erized , _and it is thought
to b e primarily a hyp e rtrophic r esponse .

Water uptake in th e uterus

of estradiol t reated rats r eaches a peak 4 to 6 ho urs after hormone
tr eat men t.

The initial water inhibition was follo wed by a second

simil ar r esponse after 12 h ours {Mueller , 1971).

Uterine we t weight ,

measur e d 2 4 hours afte r hor mone administration to ovari e ctomi zcd
r a ts, h as b een shown to i ncrease appr o ximate ly 1 90 p e rcent above
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untreated controls (Hamilton~ al., 1968).

In our study, uterine wet

weight alterations seen in 25-30 day old female rats follo w ing
estradiol treatment were sirnilar to those previously report e d (Figure
4).

The physiological effects characte ristic of estradiol we re evident

throughout the period uterine his tone acetylation was monitored.

It is

difficult at this time to pre sent a complete ly satisfactory explanation
of the biological rol e this hormone plays in its initial action on hi stone
acetylation in its target organ.

Barker (1971) showed that the

synthesis of arginine -rich his tones in rat uterus follo w ing estradiol
tr eatment was elevated immedia t e ly.

The rat e of synthesis dee r eased

to w ard control l eve ls 6 hours after tr eatmen t and then b ec ame
ste adily e l e vate d to a 22-fold in c reas e 48 hours follo wi ng estradiol.
Surprisingly, the amount of arginine-rich histone p er ut e rus decreased
dr amatically to 44 p ercent of control l eve ls 1 hour follo wing es tra diol
admi n istr ati on, r emaining depressed until appr o ximate ly 10 hours
afte r estradiol when it returned to control levels; a nd th en when
measured 12 ho urs following hormone t reatment , the y
elevated to 13 8 p ercent of co n t ro l values.

b~came

Estradiol mediated altera-

tio ns i n uterine h is tone synthesi s and content observed in th ese studies
som.ewhat p a ralleled the pattern of alte r ati o ns i n hi s t one acclylation
r eported in our work .
These results m ay offe r an explanation of some of the alterations
ob se r ved following estradio l adm.inistration.

Barker (1 97 1) suggests
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that hydrolysis of his tone protein may account for its disappearance
in the uterus immediately following estradiol treatment.

Paik and

Lee (1970; 1971) have reported an enzyme which specifically
hydrolyzes histone protein.

Earlier, Goodall (1965) reported an

increase in uterine proteolytic a.cti vity following es tradiol adminis tration.

We suggest that, if such an enzyme exists in the uterus, the

elevation of its activity by estradiol, either through activation mechanisms or through de novo synthesis, would account for the rapid
depression in arginine-rich histone content in the estradiol treated
uterus.

Control mechanisms involved in the depression of his tone

content by the hormone might also be responsible for a decrease in the
activity of an enzyme involved in the control of his tone modification.
Any continuation of the normal cellular levels of uterine his tone
acetylation in the face of rapidly decreasing his tone levels following
estradiol would not be efficient, whereas a corresponding decrease in
enzyme activity to parallel the depleted uterine histone content would
be reasonable.

As the highly elevated rate of hi stone synthesis

negated the effect of elevated his tone degradation, normal histone
levels would be reestablished and a "feedback" type of control of
hormonal stirnulation would be accorn.plished.

A return of uterine

his tone acetylation capacity foll0wing e stradiol would be expected to
follow the observed rise in his tone content, since histone modification
would again b e re qui red.
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Barker 1 s observation that the levels of uterine arginine -rich
histones were elevated to above control values 12 hours after estradiol
coupled with our findings that such elevation precedes the reversal in
the initial depression in his tone acetylation, are consistent with this
proposed model of estradiol mediated alterations in his tone metabolism.

We suggest that an alteration in histone metapolism other

than by acetylation may be implicated in the initial de repression
mechanisms thought to occur in the estradiol stimulated rat uterus.
Our previous study established that estradiol elevates uterine
his tone acetylation when measured 24 hours following hormone
treatment.

Furthermore, phenylglyoxal depressed this parameter

with peak depression in activity occurring 4 hours following drug
administration.

By aligning these time intervals, it was possible to

measure the effect of glyoxal treatment on the established elevation of
uterine histone acetylation 24 hours after hormone treatinent.
Uterine wet weight was utilized as a secondary measurable parameter
to monitor the net physiological action of e stradiol and phenylglyoxal.
The data obtained from this study suggest that 4 hour treatment with
either rn.ethylglyoxal or phenylglyoxal is ineffective in itself in altering
uterine wet weight significantly (Tables 6, 7).

Similarly, the

elevations in uterine wet weight in estradiol treated animals receiving
phenylglyoxal or methylglyoxal suggest that the glyoxals do not reverse
the initial uterine hypertrophy following horm.one treatment manifest
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at the time of glyoxal administration.

These data are consistent with

the view that early water imbibition of the uterus, which accounts for
most of the elevated uterine wet weight following estradiol, is an
extragenomic action of the hormone.

Ui and Mueller (1963) have

shown that water imbibition of the uterus following estradiol takes
place even when uterine RNA synthesis has been

blocl~ed

by actino-

mycin-D; their findings support the contention that the process of
uterine imbibition is not completely under genornic control.

It is

the ref ore conceivable that the depression of uterine hi stone acetylation
activity by methylglyoxal and phenylglyoxal treatment or the apparent
reversal of the estradiol mediated elevation in enzyme activity (Table s
6, 7; Figures 5, 6) might not be expected to influence all

n~easurable

parame ters in th e ute rus in a parall e l manne r.
An analysis of uterine tissue obtained from phenylglyoxal treat e d
animals 4 hours after drug administ ration failed to show any alteration
in the parame t e rs monitored in this study (Table 10).

Sinc e uterine

histone acetylation is depressed by this treatment , it is evident that the
depr esse d enzyme activity precedes any measurable alteration in
nucle ic acids and prote in content , as refl e ct ed by the total DNA,
RNA/DNA and protein /DNA ratios.

Pogo~

al. (1966) reported that

RNA synthesis in equine polymorphonuclear l euc ocytes following treatment with phytohemaglutinin in vitro was diminished.

Furthe rmore,

preliminary experiments suggest that an inhibition of histone acetylation

/!
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in this system may precede the observed decrease in RNA synthesis.
Since we have measured levels rather than synthesis of uterine
nucleic acids follo'vving 4 hours glyoxal treatment, it was not unex-

pected that little or no alteration in nucleic acid content following
short term glyoxal treatment was noted.

However, by extending the

period of glyoxal treatment from 4 to 48 hours, it was_ possible to
demonstrate a more pronounced effect of phenylglyoxal on the uterus
of e stradiol treated animals.

Although phenylglyoxal does not lower

uterine wet weight when given alone, the drug is capable ·of dee reasing
the magnitude of uterine weight gain seen after administration of the
hormone (Table 11).

This action is significant in that it demonstrates

th e ability of an endogenous metabolite to interfere with the physiclogical action of a steroid hormone.

Alterations of nucleic acid and

protein constituents of the estrogen stimulated uterus become
apparent when measured in phenylglyoxal pretreated animals receiving
the hormone (Table 12).

Elevations in total uterine DNA and the

protein/DNA ratio following e stradiol are not attained in phenylglyoxal
pretreated animals (Table 13).

Phenylglyoxal apparently does not

affect th e estrogen mediated elevation of the DNA/RNA ratio.

These

data are in general agreement 'vvith other studi e s concerned with the
action of the glyoxals in various biological systems.

In studies using

human kidney cells, Scaife (1969) found that kethoxal and m e thylglyoxal were potent inhibitors of protein synthesis in this system; DNA

•
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synthesis was partially blocked, whereas RNA synthesis was only
slightly influenced.

A similar pattern of glyoxal mediated alterations

in DNA, RNA and protein synthesis has been described by SzentGyorgyi. ( 196 7).

Klame rth (1968) has also reported that the principal

effect of glyoxal (0. 5mM) on human cells grown in culture is a
depression in both DNA and protein synthesis, leading him to believe
that DNA replication rather than transcription is being blocked by the
glyoxals.
In light of the results presented here and in related studies, the
possible consequences of glyoxal mediated inhibition of the acetylation
of hi stones involved in the control of DNA replication warrant consideration if a mechanism of action is to be determined for the known
biological activity of the ketoaldehydes.

If the ketoaldehyde s are

important agents in the regulation of hi stone acetylation, this suggests
that they may be therapeutically useful in inducing a termination of
cellular pro life ration.

• f

-

VI.

SUMMARY AND CONCLUSIONS

The ke toaldehydes, phenylglyoxal and methylglyoxal, inhibit the
in vitro acetylation of his tones by a cell-free soluble fraction of rat
uterus.

The degree of enzyme inhibition is dose related.

As deter-

mined by the reported I 50 value for each drug, methylglyoxal and
phenylglyoxal are equally effective in inhibiting his tone acetylation.
In vitro inhibition of uterine histone acetylation by phenylglyoxal
is thought to be accomplished primarily by inhibition of the uterine
enzyme system.

However, the formation of a glyoxal-histone complex

which is a product less capable of undergoing acetylation is also
suggested by our data.

The importance of these actions in vivo cannot

be assessed at this time.
Immature female rats treated for six days with glyoxal monohydrate gain less weight than vehicle treated controls, whereas
Methyl-GAG had no effect on this pararneter.

The decrease in uterine

wet weight following glyoxal treatment was not as evidence in MethylGAG treated rats.

Estradiol mediated elevations in uterine /body ratios

are blocked or reversed by prior treatment with Methyl-GAG and
glyoxal monohydrate, respectively.

Uterine /body weight ratios but

not liver/body weight ratios were altered when rn.e asured in animals
receiving the glyoxals and estradiol.
The hormonally stimulated immature rat uterus was develop e d
as a model system in which to measure estradiol and ketoaldehyde
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induced alterations in uterine his tone acetylation.

Various para-

meters were monitored in order to delineate more clearly the
actions of both the glyoxals and estradiol on the physiology and biochemistry of the system under study.

The temporal relationships of

the alterations induced by these agents may offer an alternate explanation for the biological action of both the hormone anc! the propos ed
inhibitor.
A rapid depression in uterine his tone acetylation occur red
follo wing estradiol administration to immature rats.

The initial

hormonal action on uterine his tone acetylation was reversed over the
initial 24 hours, leading to an elevation above control levels.

The

depression in utc rine hi stone acetylation occur red during the period in
which hormonally induced elevati o ns in uterine wet weight were
obs erved.

These findings suggest that an elevation in hi stone acetyl-

ation may not be an initial event in the general stimulation of the
immature uterus by estradiol.
Four hour tr eatment with methylglyoxal and phenylglyoxal
reversed the estradiol mediated elevation in uterine his tone acetylation,
without affecting uterine wet weight.

The phenylglyoxal mediated

inhibition of uterine his tone acetylation preceded any alteration in
uterine wet weight , total DNA, RNA/DNA or protein/DNA ratio.
When the duration of phenylglyoxal treatment was extended to
48 hours in order to measure the effectiveness of the drug in altering
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the actions of estradiol on various parameters of the model system
under study, depressions in uterine RNA/DNA and protein/DNA
ratios occurred.

Estradiol-mediated elevations in uterine wet weight,

total DNA and the protein/DNA ratio were partially blocked by this
treatment.

The drug was ineffective in blocking the elevation in

RNA/DNA ratio produced by estradiol.

The alteration of normal

physiological activity in the immature rat uterus by phenylglyoxal
became most apparent when this action was monitored in a hormonally
activated system.
Although no direct correlation between the initially depressed
rate of hi stone acetylation preceding the decrease of uterine nucleic
acid levels can be made, we suggest that blockade of the normal
pattern of histone modification following hormone adn1inistration may
lead to parallel depressions in levels of key intermediates necessary
for the complete accornplishment of hormonal action.

,. .
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The data presented in this appendix is complementary in nature
and serves to more clearly characterize the uterine histone acetylation system employed in this study.
Significant

h~stone

acetylation activity was observed in the mito-

chondrial, microsomal and supernatant (100, 000 x g) -fraction of rat
uterus obtained from immature (25 day old) rats.

Specific activities of

16, 255, 31, 219 and 157, 563 DPM/mg protein were observed for these
fractions, respectively {Appendix A).

These data, expr~ s sed as

percent total activity versus percent total protein is represented in
Appendix B.

Enzyme activity was highest in the soluble (supernatant)

rat uterus fraction.
The effect of temperature on in vitro his tone acetylation is
represented in Appendix C.
0

0

Enzyme activity remains constant from

30 c to 38 c followed by an abrupt el.e vation at

rl:Jr.

4u-~

assay temperature.

Enzyme activity decline d sharply as the temperature exceeded 40°C
and approach e d 60°C.

The 0 10 (37-45°C) value of the acetylating

enzyme system is 1. 77.
0

The elevation in histone ac e tylation activity at 40 C was used as
a basis for studying reversibility of this activity.

Enzyme preparations

preincubate d at an elevated temp e rature (40°C) retained their elevated
acetylation activity when assaye d at the standard incubation temper ature of 37°c {Appe ndix D).

Enzyme pr e parations containing equal
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aliquots of enzyme preincubated at 37°C and at 40°C demonstrated
activity slightly less than additive

APPENDIX A
Subcellular Localization and Specific Activity of Histone Acetylation
In Immature Rat Uterus
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Fractiona

Nuclei

Specific Activity
(dpm/mg protein)

Percent of
Total Activity

4,610

2.2

Mitochondria

16,255

7.8

Microsomes

31,219

14.8

157,563

75.2

Supernatant
(105, 000 x g)

aA weighed sample of rat uterus was homogenized in
0. 25M sucrose and centrifug ed at 780 x g for 15
minutes, and 105, 000 x g for 60 minutes to obtain
nuclear, mitochondrial, and microsomal pellets,
respectively. Pellets we re washed in 0. 25M sucrose and
resuspended to volume in Robinson's media (Robinson,
1949). A 0. 05 ml aliquot of each fraction was used as
enzyme source fo"r assay of his tone acetylation.

APPENDIX B
Subcellular Localization and Spe cific Activity of Hi stone Acetylation
In Immature Rat Uterus
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APPENDIX C
Effect of Temperature on i:h vitro His tone Acetylation
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APPENDIX D
In vitro Thermal Activation of His tone Acetylation Properties of
Rat Uterine Supernatant Fraction
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Series

Preincubation
Temperature

Assay
Temperature

Hi stone
Acetylation
{dpm/mg Histone)
Mean"!: S. E.

*

Ia

37°c

37°c

13, 793 ~ 1885

_nb

40°c

37°c

26,313 ~ 2680

IIIC

37°c
400C

37°c

18,220 ~ 1115

aStandard assay system using 10, 000 x g rat uterine fraction (0. 1 ml)
preincubated for 20 min at 37°C, cooled on ice and added to complete
assay system for incubation at 37°c for an additional 15 min. Prior
to incubation, uterine fraction was diluted (1:1) with Robinson's media.
bStandard assay system using 10, 000 x g rat uterine fraction (0. 1 ml)
preincubated for 20 min at 40°C, cooled on ice and added to complete
as say system for incubation at 37°c for an additional 15 min.
Uterine fraction was diluted (1:1) as above.
cStandard assay system using combined supernatant fraction prepared
by mixing O. 1 ml aliquots of undiluted Series I and II treated supernatant with O. 2 ml Robinson's media . At time of assay, 0. 1 ml of
final mixture was added to complete assay system for incubation at
37°c for 15 min.

*Mean~

S. E. (for three determinations).

